Grant: A phase I, multi-centre, randomised, placebo-controlled, dose escalation study to assess the local and systemic tolerability of the therapeutic DNA plasmid pdpSC18 vaccine administered by particle mediated epidermal delivery using the powderject ND 10 delivery system in subjects with chronic hepatitis B infection

  • Basic View
  • XML View
Project Title
A phase I, multi-centre, randomised, placebo-controlled, dose escalation study to assess the local and systemic tolerability of the therapeutic DNA plasmid pdpSC18 vaccine administered by particle mediated epidermal delivery using the powderject ND 10 delivery system in subjects with chronic hepatitis B infection
 
Principal Investigator Yuen, Richard Man Fung (Principal investigator)
Funding Year
2005/2006
 
Amount
30700
 
Start Date
01-11-2006
 
Expected Completion
31-10-2007
 
Status
On-going
 
Keywords Chronic Hepatitis B
Sponsor Other projects
Grant Type/Funding Scheme PowderMed Ltd - General Award
Duration
12
 
[Coming Soon]